Roy N, Carpenter A, Dale-Harris I, Doree C, Estcourt L
Cochrane Database Syst Rev. 2023; 8:CD012380.
PMID: 37539955
PMC: 10404133.
DOI: 10.1002/14651858.CD012380.pub3.
Baxter C, Crary I, Coler B, Marcell L, Huebner E, Rutz S
Am J Obstet Gynecol. 2023; 229(6):647-655.
PMID: 37516401
PMC: 10818026.
DOI: 10.1016/j.ajog.2023.07.042.
Geneen L, Doree C, Estcourt L
Cochrane Database Syst Rev. 2023; 3:CD012349.
PMID: 36877640
PMC: 9987409.
DOI: 10.1002/14651858.CD012349.pub3.
Kimyon G, Ilhan G
Turk J Med Sci. 2022; 52(5):1721-1728.
PMID: 36422487
PMC: 10395667.
DOI: 10.55730/1300-0144.5515.
Feng Y, Ma F, Wu E, Cheng Z, Wang Z, Yang L
Front Pharmacol. 2022; 13:922029.
PMID: 36386161
PMC: 9659574.
DOI: 10.3389/fphar.2022.922029.
Biomaterials-Mediated Tumor Infarction Therapy.
Tong S, Zhao W, Zhao D, Zhang W, Zhang Z
Front Bioeng Biotechnol. 2022; 10:916926.
PMID: 35757801
PMC: 9218593.
DOI: 10.3389/fbioe.2022.916926.
Kidney Transplantation With a Sickle Cell Disease Donor.
Philipponnet C, Aniort J, Garrouste C, Kemeny J, Hadj-Abdelkader M, Heng A
Kidney Int Rep. 2020; 5(10):1836-1838.
PMID: 33102979
PMC: 7569695.
DOI: 10.1016/j.ekir.2020.07.039.
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt L, Kohli R, Hopewell S, Trivella M, Wang W
Cochrane Database Syst Rev. 2020; 7:CD003146.
PMID: 32716555
PMC: 7388696.
DOI: 10.1002/14651858.CD003146.pub4.
Preoperative blood transfusions for sickle cell disease.
Estcourt L, Kimber C, Trivella M, Doree C, Hopewell S
Cochrane Database Syst Rev. 2020; 7:CD003149.
PMID: 32614473
PMC: 7389247.
DOI: 10.1002/14651858.CD003149.pub4.
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt L, Kimber C, Hopewell S, Trivella M, Doree C, Abboud M
Cochrane Database Syst Rev. 2020; 4:CD012389.
PMID: 32250453
PMC: 7134371.
DOI: 10.1002/14651858.CD012389.pub3.
Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease.
Estcourt L, Hopewell S, Trivella M, Hambleton I, Cho G
Cochrane Database Syst Rev. 2019; 2019(10).
PMID: 31684693
PMC: 6814284.
DOI: 10.1002/14651858.CD008360.pub5.
Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
Fortin P, Hopewell S, Estcourt L
Cochrane Database Syst Rev. 2018; 8:CD012082.
PMID: 30067867
PMC: 6513377.
DOI: 10.1002/14651858.CD012082.pub2.
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Fortin P, Fisher S, Madgwick K, Trivella M, Hopewell S, Doree C
Cochrane Database Syst Rev. 2018; 5:CD012349.
PMID: 29737522
PMC: 5985157.
DOI: 10.1002/14651858.CD012349.pub2.
Interventions for chronic kidney disease in people with sickle cell disease.
Roy N, Fortin P, Bull K, Doree C, Trivella M, Hopewell S
Cochrane Database Syst Rev. 2017; 7:CD012380.
PMID: 28672087
PMC: 5544118.
DOI: 10.1002/14651858.CD012380.pub2.
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt L, Fortin P, Hopewell S, Trivella M, Doree C, Abboud M
Cochrane Database Syst Rev. 2017; 5:CD012389.
PMID: 28500860
PMC: 5460750.
DOI: 10.1002/14651858.CD012389.pub2.
Interventions for chronic kidney disease in people with sickle cell disease.
Roy N, Fortin P, Bull K, Doree C, Trivella M, Hopewell S
Cochrane Database Syst Rev. 2017; 2016(10).
PMID: 28344511
PMC: 5360229.
DOI: 10.1002/14651858.CD012380.
Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt L, Fortin P, Hopewell S, Trivella M, Doree C, Abboud M
Cochrane Database Syst Rev. 2017; 2016(10).
PMID: 28344510
PMC: 5360228.
DOI: 10.1002/14651858.CD012389.
Patient-specific modeling of individual sickle cell behavior under transient hypoxia.
Li X, Du E, Dao M, Suresh S, Karniadakis G
PLoS Comput Biol. 2017; 13(3):e1005426.
PMID: 28288152
PMC: 5367819.
DOI: 10.1371/journal.pcbi.1005426.
Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt L, Fortin P, Hopewell S, Trivella M, Wang W
Cochrane Database Syst Rev. 2017; 1:CD003146.
PMID: 28094851
PMC: 6464911.
DOI: 10.1002/14651858.CD003146.pub3.
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemia.
Fortin P, Madgwick K, Trivella M, Hopewell S, Doree C, Estcourt L
Cochrane Database Syst Rev. 2016; 2016(9).
PMID: 27713668
PMC: 5047353.
DOI: 10.1002/14651858.CD012349.
